Linked Life Data

2504801

Source:http://linkedlifedata.com/resource/pubmed/id/2504801

Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
3 Suppl A
pubmed:dateCreated
1989-10-12
pubmed:abstractText
Clinical decision models are intended to guide the choices of individual clinicians; policy models are intended to guide the choices of persons and organizations that affect the aggregate allocations of resources to health care problems. Although it is difficult to identify any single policymaker in the United States who can alter the aggregate effect of the millions (or billions) of individual clinical decisions, there are many potential users of policy models: payers, providers, state and local health departments, the National Institutes of Health, professional organizations, hospitals and producers of medical devices, among others. Policy models deal with populations of individuals, may be static or dynamic and may be descriptive or prescriptive. Two types of policy models that have been applied to cardiovascular disease with a focus on coronary artery bypass surgery are discussed: 1) economic evaluation models, specifically cost-effectiveness, cost utility and cost-benefit analyses; and 2) population simulation models. Cost-effectiveness models are preferable for reasons that are discussed.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
AIM
pubmed:status
MEDLINE
pubmed:month
Sep
pubmed:issn
0735-1097
pubmed:author
pubmed:issnType
Print
pubmed:volume
14
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
38A-43A
pubmed:dateRevised
2006-11-15
pubmed:meshHeading
pubmed:year
1989
pubmed:articleTitle
Methodologic issues in policy modeling for cardiovascular disease.
pubmed:affiliation
Department of Biostatistics and Health Policy and Management, Harvard School of Public Health, Boston, Massachusetts 02115.
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't